Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spencer Behr

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
ACS Nano|November 23, 2017
Magnetic Particle Imaging for Highly Sensitive, Quantitative, and Safe in Vivo Gut Bleed Detection in a Murine ModelElaine Y Yu, Prashant Chandrasekharan, Ran Berzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
Annals of Surgery|August 23, 2024
A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal AdenocarcinomaJane Wang, Amir Ashraf Ganjouei, Fernanda Romero-Hernandez, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
The New England Journal of Medicine|September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsJennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Nuclear Medicine and Biology|November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology|March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachFrederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
ACS Nano|November 23, 2017
Magnetic Particle Imaging for Highly Sensitive, Quantitative, and Safe in Vivo Gut Bleed Detection in a Murine ModelElaine Y Yu, Prashant Chandrasekharan, Ran Berzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter StudyStefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
Annals of Surgery|August 23, 2024
A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal AdenocarcinomaJane Wang, Amir Ashraf Ganjouei, Fernanda Romero-Hernandez, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
The New England Journal of Medicine|September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsJennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Nuclear Medicine and Biology|November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology|March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachFrederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Pageof 4